img

Global Peptide Therapy Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Peptide Therapy Market Research Report 2024

Peptide therapy refers to restoring the amount of peptides to stimulate the cellular regeneration system in the body, and can be an excellent complement to small molecule and biotherapeutics as a treatment option under certain conditions. The most common uses of peptide therapy are to help build muscle and reduce fat, increase energy, improve sexual function, and reduce gastrointestinal and musculoskeletal inflammation. The most common prescription peptide combinations naturally boost growth hormone for better recovery. Peptides were initially used only for diagnostics and hormone therapy; however, as technology has advanced, they are now also widely used to treat cancer and chronic metabolic diseases. Peptides are also used in cosmeceutical operations to slow down the skin's aging process. Naturally occurring peptides are strings of amino acids present in all living organisms. Peptide therapy is used to treat various diseases. The peptide acts as an anti-infective growth hormone and even as an ion channel ligand. Peptide therapy can perform the same function. Developments in the global biotech and pharmaceutical industries have proven that peptide therapy can stimulate essential hormones. As we age, our body's endopeptide production is disturbed. Peptide therapy safely and effectively reintroduces important peptides into the body. Peptide therapy can treat neurological problems, diabetes, cancer, heart problems and many other diseases. In addition, peptide therapy can also improve muscle endurance, pain relief, injury recovery and aid in weight loss. During treatment, the peptides are delivered directly into the blood. Peptide therapeutics are growing rapidly in the pharmaceutical and biotech industries. Peptide therapy has grown in popularity in the global nutrition industry in recent years. Moreover, the global healthcare industry has rapidly adopted peptide drug delivery options. Peptide therapy has positively impacted human health by improving stamina and immunity and reducing adverse side effects caused by long-term chronic diseases. Rising geriatric population is the major driving factor for the development of the peptide therapeutics market. Furthermore, technological advancements in the pharmaceutical industry are considered to drive the growth of the market over the forecast period 2024 to 2032. Various peptide conjugates help reduce inflammation, act as antioxidants and promote weight loss. Booming health and nutrition industry is driving the demand for peptide drugs.
According to Mr Accuracy reports new survey, global Peptide Therapy market is projected to reach US$ 62820 million in 2029, increasing from US$ 43110 million in 2022, with the CAGR of 5.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Peptide Therapy market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Peptide Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Eli Lilly
AstraZeneca
Merck
Ipsen
Novo Nordisk
Teva Pharmaceutical Industries
Abbott Laboratories
Sanofi
J & J
Novartis
Takeda
Ferring
AbbVie
Heinis
Hemmo
Emcure Pharmaceutical
Cipla
Gland Pharma
Troikaa Pharmaceuticals
Biological E
Segment by Type
Parenteral Route of Administration
Mucosal Route of Administration
Oral Route of Administration
Transdermal Route of Administration

Segment by Application


Cancer
Cardiovascular Diseases
Gastrointestinal Disorders
Metabolic Disorders
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Peptide Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Peptide Therapy Market Overview
1.1 Product Overview and Scope of Peptide Therapy
1.2 Peptide Therapy Segment by Type
1.2.1 Global Peptide Therapy Market Value Comparison by Type (2024-2034)
1.2.2 Parenteral Route of Administration
1.2.3 Mucosal Route of Administration
1.2.4 Oral Route of Administration
1.2.5 Transdermal Route of Administration
1.3 Peptide Therapy Segment by Application
1.3.1 Global Peptide Therapy Market Value by Application: (2024-2034)
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Gastrointestinal Disorders
1.3.5 Metabolic Disorders
1.3.6 Others
1.4 Global Peptide Therapy Market Size Estimates and Forecasts
1.4.1 Global Peptide Therapy Revenue 2018-2029
1.4.2 Global Peptide Therapy Sales 2018-2029
1.4.3 Global Peptide Therapy Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Peptide Therapy Market Competition by Manufacturers
2.1 Global Peptide Therapy Sales Market Share by Manufacturers (2018-2024)
2.2 Global Peptide Therapy Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Peptide Therapy Average Price by Manufacturers (2018-2024)
2.4 Global Peptide Therapy Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Peptide Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peptide Therapy, Product Type & Application
2.7 Peptide Therapy Market Competitive Situation and Trends
2.7.1 Peptide Therapy Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Peptide Therapy Players Market Share by Revenue
2.7.3 Global Peptide Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Peptide Therapy Retrospective Market Scenario by Region
3.1 Global Peptide Therapy Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Peptide Therapy Global Peptide Therapy Sales by Region: 2018-2029
3.2.1 Global Peptide Therapy Sales by Region: 2018-2024
3.2.2 Global Peptide Therapy Sales by Region: 2024-2029
3.3 Global Peptide Therapy Global Peptide Therapy Revenue by Region: 2018-2029
3.3.1 Global Peptide Therapy Revenue by Region: 2018-2024
3.3.2 Global Peptide Therapy Revenue by Region: 2024-2029
3.4 North America Peptide Therapy Market Facts & Figures by Country
3.4.1 North America Peptide Therapy Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Peptide Therapy Sales by Country (2018-2029)
3.4.3 North America Peptide Therapy Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Peptide Therapy Market Facts & Figures by Country
3.5.1 Europe Peptide Therapy Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Peptide Therapy Sales by Country (2018-2029)
3.5.3 Europe Peptide Therapy Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peptide Therapy Market Facts & Figures by Country
3.6.1 Asia Pacific Peptide Therapy Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Peptide Therapy Sales by Country (2018-2029)
3.6.3 Asia Pacific Peptide Therapy Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Peptide Therapy Market Facts & Figures by Country
3.7.1 Latin America Peptide Therapy Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Peptide Therapy Sales by Country (2018-2029)
3.7.3 Latin America Peptide Therapy Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peptide Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Peptide Therapy Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Peptide Therapy Sales by Country (2018-2029)
3.8.3 Middle East and Africa Peptide Therapy Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Peptide Therapy Sales by Type (2018-2029)
4.1.1 Global Peptide Therapy Sales by Type (2018-2024)
4.1.2 Global Peptide Therapy Sales by Type (2024-2029)
4.1.3 Global Peptide Therapy Sales Market Share by Type (2018-2029)
4.2 Global Peptide Therapy Revenue by Type (2018-2029)
4.2.1 Global Peptide Therapy Revenue by Type (2018-2024)
4.2.2 Global Peptide Therapy Revenue by Type (2024-2029)
4.2.3 Global Peptide Therapy Revenue Market Share by Type (2018-2029)
4.3 Global Peptide Therapy Price by Type (2018-2029)
5 Segment by Application
5.1 Global Peptide Therapy Sales by Application (2018-2029)
5.1.1 Global Peptide Therapy Sales by Application (2018-2024)
5.1.2 Global Peptide Therapy Sales by Application (2024-2029)
5.1.3 Global Peptide Therapy Sales Market Share by Application (2018-2029)
5.2 Global Peptide Therapy Revenue by Application (2018-2029)
5.2.1 Global Peptide Therapy Revenue by Application (2018-2024)
5.2.2 Global Peptide Therapy Revenue by Application (2024-2029)
5.2.3 Global Peptide Therapy Revenue Market Share by Application (2018-2029)
5.3 Global Peptide Therapy Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Eli Lilly Peptide Therapy Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.2.4 AstraZeneca Peptide Therapy Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Merck Peptide Therapy Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Ipsen
6.4.1 Ipsen Corporation Information
6.4.2 Ipsen Description and Business Overview
6.4.3 Ipsen Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Ipsen Peptide Therapy Product Portfolio
6.4.5 Ipsen Recent Developments/Updates
6.5 Novo Nordisk
6.5.1 Novo Nordisk Corporation Information
6.5.2 Novo Nordisk Description and Business Overview
6.5.3 Novo Nordisk Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Novo Nordisk Peptide Therapy Product Portfolio
6.5.5 Novo Nordisk Recent Developments/Updates
6.6 Teva Pharmaceutical Industries
6.6.1 Teva Pharmaceutical Industries Corporation Information
6.6.2 Teva Pharmaceutical Industries Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Teva Pharmaceutical Industries Peptide Therapy Product Portfolio
6.6.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Abbott Laboratories Peptide Therapy Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Sanofi Peptide Therapy Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 J & J
6.9.1 J & J Corporation Information
6.9.2 J & J Description and Business Overview
6.9.3 J & J Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.9.4 J & J Peptide Therapy Product Portfolio
6.9.5 J & J Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Novartis Peptide Therapy Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Takeda
6.11.1 Takeda Corporation Information
6.11.2 Takeda Peptide Therapy Description and Business Overview
6.11.3 Takeda Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Takeda Peptide Therapy Product Portfolio
6.11.5 Takeda Recent Developments/Updates
6.12 Ferring
6.12.1 Ferring Corporation Information
6.12.2 Ferring Peptide Therapy Description and Business Overview
6.12.3 Ferring Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Ferring Peptide Therapy Product Portfolio
6.12.5 Ferring Recent Developments/Updates
6.13 AbbVie
6.13.1 AbbVie Corporation Information
6.13.2 AbbVie Peptide Therapy Description and Business Overview
6.13.3 AbbVie Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.13.4 AbbVie Peptide Therapy Product Portfolio
6.13.5 AbbVie Recent Developments/Updates
6.14 Heinis
6.14.1 Heinis Corporation Information
6.14.2 Heinis Peptide Therapy Description and Business Overview
6.14.3 Heinis Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Heinis Peptide Therapy Product Portfolio
6.14.5 Heinis Recent Developments/Updates
6.15 Hemmo
6.15.1 Hemmo Corporation Information
6.15.2 Hemmo Peptide Therapy Description and Business Overview
6.15.3 Hemmo Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Hemmo Peptide Therapy Product Portfolio
6.15.5 Hemmo Recent Developments/Updates
6.16 Emcure Pharmaceutical
6.16.1 Emcure Pharmaceutical Corporation Information
6.16.2 Emcure Pharmaceutical Peptide Therapy Description and Business Overview
6.16.3 Emcure Pharmaceutical Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Emcure Pharmaceutical Peptide Therapy Product Portfolio
6.16.5 Emcure Pharmaceutical Recent Developments/Updates
6.17 Cipla
6.17.1 Cipla Corporation Information
6.17.2 Cipla Peptide Therapy Description and Business Overview
6.17.3 Cipla Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Cipla Peptide Therapy Product Portfolio
6.17.5 Cipla Recent Developments/Updates
6.18 Gland Pharma
6.18.1 Gland Pharma Corporation Information
6.18.2 Gland Pharma Peptide Therapy Description and Business Overview
6.18.3 Gland Pharma Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Gland Pharma Peptide Therapy Product Portfolio
6.18.5 Gland Pharma Recent Developments/Updates
6.19 Troikaa Pharmaceuticals
6.19.1 Troikaa Pharmaceuticals Corporation Information
6.19.2 Troikaa Pharmaceuticals Peptide Therapy Description and Business Overview
6.19.3 Troikaa Pharmaceuticals Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Troikaa Pharmaceuticals Peptide Therapy Product Portfolio
6.19.5 Troikaa Pharmaceuticals Recent Developments/Updates
6.20 Biological E
6.20.1 Biological E Corporation Information
6.20.2 Biological E Peptide Therapy Description and Business Overview
6.20.3 Biological E Peptide Therapy Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Biological E Peptide Therapy Product Portfolio
6.20.5 Biological E Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peptide Therapy Industry Chain Analysis
7.2 Peptide Therapy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peptide Therapy Production Mode & Process
7.4 Peptide Therapy Sales and Marketing
7.4.1 Peptide Therapy Sales Channels
7.4.2 Peptide Therapy Distributors
7.5 Peptide Therapy Customers
8 Peptide Therapy Market Dynamics
8.1 Peptide Therapy Industry Trends
8.2 Peptide Therapy Market Drivers
8.3 Peptide Therapy Market Challenges
8.4 Peptide Therapy Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Peptide Therapy Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Peptide Therapy Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Peptide Therapy Market Competitive Situation by Manufacturers in 2022
Table 4. Global Peptide Therapy Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Peptide Therapy Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Peptide Therapy Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Peptide Therapy Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Peptide Therapy Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Peptide Therapy, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Peptide Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peptide Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Peptide Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peptide Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapy as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peptide Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Peptide Therapy Sales by Region (2018-2024) & (K Units)
Table 18. Global Peptide Therapy Sales Market Share by Region (2018-2024)
Table 19. Global Peptide Therapy Sales by Region (2024-2029) & (K Units)
Table 20. Global Peptide Therapy Sales Market Share by Region (2024-2029)
Table 21. Global Peptide Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Peptide Therapy Revenue Market Share by Region (2018-2024)
Table 23. Global Peptide Therapy Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Peptide Therapy Revenue Market Share by Region (2024-2029)
Table 25. North America Peptide Therapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 27. North America Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 28. North America Peptide Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Peptide Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Peptide Therapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 32. Europe Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 33. Europe Peptide Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Peptide Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Peptide Therapy Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Peptide Therapy Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Peptide Therapy Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Peptide Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Peptide Therapy Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Peptide Therapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Peptide Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Peptide Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Peptide Therapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Peptide Therapy Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Peptide Therapy Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Peptide Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Peptide Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Peptide Therapy Sales (K Units) by Type (2018-2024)
Table 51. Global Peptide Therapy Sales (K Units) by Type (2024-2029)
Table 52. Global Peptide Therapy Sales Market Share by Type (2018-2024)
Table 53. Global Peptide Therapy Sales Market Share by Type (2024-2029)
Table 54. Global Peptide Therapy Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Peptide Therapy Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Peptide Therapy Revenue Market Share by Type (2018-2024)
Table 57. Global Peptide Therapy Revenue Market Share by Type (2024-2029)
Table 58. Global Peptide Therapy Price (US$/Unit) by Type (2018-2024)
Table 59. Global Peptide Therapy Price (US$/Unit) by Type (2024-2029)
Table 60. Global Peptide Therapy Sales (K Units) by Application (2018-2024)
Table 61. Global Peptide Therapy Sales (K Units) by Application (2024-2029)
Table 62. Global Peptide Therapy Sales Market Share by Application (2018-2024)
Table 63. Global Peptide Therapy Sales Market Share by Application (2024-2029)
Table 64. Global Peptide Therapy Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Peptide Therapy Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Peptide Therapy Revenue Market Share by Application (2018-2024)
Table 67. Global Peptide Therapy Revenue Market Share by Application (2024-2029)
Table 68. Global Peptide Therapy Price (US$/Unit) by Application (2018-2024)
Table 69. Global Peptide Therapy Price (US$/Unit) by Application (2024-2029)
Table 70. Eli Lilly Corporation Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Eli Lilly Peptide Therapy Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. AstraZeneca Peptide Therapy Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Merck Peptide Therapy Product
Table 84. Merck Recent Developments/Updates
Table 85. Ipsen Corporation Information
Table 86. Ipsen Description and Business Overview
Table 87. Ipsen Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Ipsen Peptide Therapy Product
Table 89. Ipsen Recent Developments/Updates
Table 90. Novo Nordisk Corporation Information
Table 91. Novo Nordisk Description and Business Overview
Table 92. Novo Nordisk Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Novo Nordisk Peptide Therapy Product
Table 94. Novo Nordisk Recent Developments/Updates
Table 95. Teva Pharmaceutical Industries Corporation Information
Table 96. Teva Pharmaceutical Industries Description and Business Overview
Table 97. Teva Pharmaceutical Industries Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Teva Pharmaceutical Industries Peptide Therapy Product
Table 99. Teva Pharmaceutical Industries Recent Developments/Updates
Table 100. Abbott Laboratories Corporation Information
Table 101. Abbott Laboratories Description and Business Overview
Table 102. Abbott Laboratories Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Abbott Laboratories Peptide Therapy Product
Table 104. Abbott Laboratories Recent Developments/Updates
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Sanofi Peptide Therapy Product
Table 109. Sanofi Recent Developments/Updates
Table 110. J & J Corporation Information
Table 111. J & J Description and Business Overview
Table 112. J & J Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. J & J Peptide Therapy Product
Table 114. J & J Recent Developments/Updates
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Novartis Peptide Therapy Product
Table 119. Novartis Recent Developments/Updates
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Takeda Peptide Therapy Product
Table 124. Takeda Recent Developments/Updates
Table 125. Ferring Corporation Information
Table 126. Ferring Description and Business Overview
Table 127. Ferring Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Ferring Peptide Therapy Product
Table 129. Ferring Recent Developments/Updates
Table 130. AbbVie Corporation Information
Table 131. AbbVie Description and Business Overview
Table 132. AbbVie Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. AbbVie Peptide Therapy Product
Table 134. AbbVie Recent Developments/Updates
Table 135. Heinis Corporation Information
Table 136. Heinis Description and Business Overview
Table 137. Heinis Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Heinis Peptide Therapy Product
Table 139. Heinis Recent Developments/Updates
Table 140. Hemmo Corporation Information
Table 141. Hemmo Description and Business Overview
Table 142. Hemmo Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Hemmo Peptide Therapy Product
Table 144. Hemmo Recent Developments/Updates
Table 145. Emcure Pharmaceutical Corporation Information
Table 146. Emcure Pharmaceutical Description and Business Overview
Table 147. Emcure Pharmaceutical Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Emcure Pharmaceutical Peptide Therapy Product
Table 149. Emcure Pharmaceutical Recent Developments/Updates
Table 150. Cipla Corporation Information
Table 151. Cipla Description and Business Overview
Table 152. Cipla Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Cipla Peptide Therapy Product
Table 154. Cipla Recent Developments/Updates
Table 155. Gland Pharma Corporation Information
Table 156. Gland Pharma Description and Business Overview
Table 157. Gland Pharma Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Gland Pharma Peptide Therapy Product
Table 159. Gland Pharma Recent Developments/Updates
Table 160. Troikaa Pharmaceuticals Corporation Information
Table 161. Troikaa Pharmaceuticals Description and Business Overview
Table 162. Troikaa Pharmaceuticals Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Troikaa Pharmaceuticals Peptide Therapy Product
Table 164. Troikaa Pharmaceuticals Recent Developments/Updates
Table 165. Biological E Corporation Information
Table 166. Biological E Description and Business Overview
Table 167. Biological E Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Biological E Peptide Therapy Product
Table 169. Biological E Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Peptide Therapy Distributors List
Table 173. Peptide Therapy Customers List
Table 174. Peptide Therapy Market Trends
Table 175. Peptide Therapy Market Drivers
Table 176. Peptide Therapy Market Challenges
Table 177. Peptide Therapy Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Peptide Therapy
Figure 2. Global Peptide Therapy Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Peptide Therapy Market Share by Type in 2022 & 2029
Figure 4. Parenteral Route of Administration Product Picture
Figure 5. Mucosal Route of Administration Product Picture
Figure 6. Oral Route of Administration Product Picture
Figure 7. Transdermal Route of Administration Product Picture
Figure 8. Global Peptide Therapy Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Peptide Therapy Market Share by Application in 2022 & 2029
Figure 10. Cancer
Figure 11. Cardiovascular Diseases
Figure 12. Gastrointestinal Disorders
Figure 13. Metabolic Disorders
Figure 14. Others
Figure 15. Global Peptide Therapy Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Peptide Therapy Market Size (2018-2029) & (US$ Million)
Figure 17. Global Peptide Therapy Sales (2018-2029) & (K Units)
Figure 18. Global Peptide Therapy Average Price (US$/Unit) & (2018-2029)
Figure 19. Peptide Therapy Report Years Considered
Figure 20. Peptide Therapy Sales Share by Manufacturers in 2022
Figure 21. Global Peptide Therapy Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Peptide Therapy Players: Market Share by Revenue in 2022
Figure 23. Peptide Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Peptide Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America Peptide Therapy Sales Market Share by Country (2018-2029)
Figure 26. North America Peptide Therapy Revenue Market Share by Country (2018-2029)
Figure 27. U.S. Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Peptide Therapy Sales Market Share by Country (2018-2029)
Figure 30. Europe Peptide Therapy Revenue Market Share by Country (2018-2029)
Figure 31. Germany Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Peptide Therapy Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Peptide Therapy Revenue Market Share by Region (2018-2029)
Figure 38. China Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Taiwan Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Philippines Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Peptide Therapy Sales Market Share by Country (2018-2029)
Figure 49. Latin America Peptide Therapy Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Peptide Therapy Sales Market Share by Country (2018-2029)
Figure 54. Middle East & Africa Peptide Therapy Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. U.A.E Peptide Therapy Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Sales Market Share of Peptide Therapy by Type (2018-2029)
Figure 59. Global Revenue Market Share of Peptide Therapy by Type (2018-2029)
Figure 60. Global Peptide Therapy Price (US$/Unit) by Type (2018-2029)
Figure 61. Global Sales Market Share of Peptide Therapy by Application (2018-2029)
Figure 62. Global Revenue Market Share of Peptide Therapy by Application (2018-2029)
Figure 63. Global Peptide Therapy Price (US$/Unit) by Application (2018-2029)
Figure 64. Peptide Therapy Value Chain
Figure 65. Peptide Therapy Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries